Your browser doesn't support javascript.
loading
Addition of Cyclophosphamide "On Demand" to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma-A Retrospective Review of a Single-center Experience.
Alahmadi, Majed; Masih-Khan, Esther; Atenafu, Eshetu G; Chen, Christine; Kukreti, Vishal; Tiedemann, Rodger; Trudel, Suzanne; Reece, Donna E.
Afiliação
  • Alahmadi M; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Masih-Khan E; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Atenafu EG; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Chen C; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kukreti V; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Tiedemann R; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Trudel S; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Reece DE; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address: DonnaReece@uhn.ca.
Clin Lymphoma Myeloma Leuk ; 19(4): e195-e203, 2019 04.
Article em En | MEDLINE | ID: mdl-30723035

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Alquilantes / Ciclofosfamida / Mieloma Múltiplo Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Alquilantes / Ciclofosfamida / Mieloma Múltiplo Idioma: En Ano de publicação: 2019 Tipo de documento: Article